New Heart Drug Proves Superior to Aspirin

Clinical trial found it was better at preventing heart attacks and strokes.

Patients with coronary artery disease (CAD) or peripheral artery disease (PAD) usually take a daily aspirin to help prevent their platelets from clumping together and forming clots (thrombi). This keeps their blood flowing smoothly through arteries that have been narrowed by atherosclerosis. In 2013 Bayer, the makers of the new antithrombotic drug called rivaroxaban (Xarelto), […]

Tags , , , , , , , , ,

Leave a Reply

You must be logged in to post a comment.

Enter Your Login Credentials
This setting should only be used on your home or work computer.